Latest interview, full of great nuggets: https:
Post# of 154984
(Total Views: 824)
Posted On: 04/02/2020 5:21:55 PM
Latest interview, full of great nuggets:
https://tdameritradenetwork.com/video/rB4AoXEeEvOBcTwR6_gK7Q
- Dr. Patterson comments:
* presented with patients who had severe immuno deficiencies, lung damage, multi organ failures, etc...
* pleased with saving some patients that had only one way to go
* very satisfying and starting earlier will only help as this disease spreads rapidly
* restoring immune cells by day 3
* Protects patient against other bacterial infections
* CD 8 cells back to normal range by day 7
* Normalized CD4/CD8 ratio
* Cytokine IL6 reduced by 70-90%, reduces storm and damage in lungs
- Nader comments:
* In China, similar study resulted in 31 of 32 patients dying
* Presenting data on first 8 patients to FDA today, to be followed by the other 2 as soon as data is available
* Many hospitals are signing up to participate in the next trials, mild/mod and severe. Mentioned Harvard, Mass General, Cornell, UCLA, San Fran, ....
* Working with two manufacturers ....
* Plan is to go with interim results on these next trials to FDA asap
Both of them look so confident, hold on to your hats!
https://tdameritradenetwork.com/video/rB4AoXEeEvOBcTwR6_gK7Q
- Dr. Patterson comments:
* presented with patients who had severe immuno deficiencies, lung damage, multi organ failures, etc...
* pleased with saving some patients that had only one way to go
* very satisfying and starting earlier will only help as this disease spreads rapidly
* restoring immune cells by day 3
* Protects patient against other bacterial infections
* CD 8 cells back to normal range by day 7
* Normalized CD4/CD8 ratio
* Cytokine IL6 reduced by 70-90%, reduces storm and damage in lungs
- Nader comments:
* In China, similar study resulted in 31 of 32 patients dying
* Presenting data on first 8 patients to FDA today, to be followed by the other 2 as soon as data is available
* Many hospitals are signing up to participate in the next trials, mild/mod and severe. Mentioned Harvard, Mass General, Cornell, UCLA, San Fran, ....
* Working with two manufacturers ....
* Plan is to go with interim results on these next trials to FDA asap
Both of them look so confident, hold on to your hats!
(10)
(0)